paediatrics
paediatrics

Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

BMC Med Genomics. 2024 Apr 23;17(1):101. doi: 10.1186/s12920-024-01874-y. ABSTRACT BACKGROUND: Allopurinol has been causing substantial morbidity and mortality particularly in Asian population by producing cutaneous …

Phenotypic and molecular characterization of β-lactamase-producing Klebsiella species among children discharged from hospital in Western Kenya

BMC Microbiol. 2024 Apr 23;24(1):135. doi: 10.1186/s12866-024-03284-7. ABSTRACT BACKGROUND: The emergence and spread of β-lactamase-producing Klebsiella spp. has been associated with a substantial healthcare burden …

The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking

Cardiovasc Diabetol. 2024 Apr 23;23(1):133. doi: 10.1186/s12933-024-02225-y. ABSTRACT BACKGROUND: Metabolic syndrome (MetS) can increase the risk of morbidity and mortality of cardiovascular disease and obstructive …

Prognostic value of Geriatric-8 for adverse outcomes within 30 days of surgery in older adults with colorectal cancer: A retrospective cohort study

Eur J Oncol Nurs. 2024 Apr 16;70:102591. doi: 10.1016/j.ejon.2024.102591. Online ahead of print. ABSTRACT PURPOSE: It is unclear whether the Geriatric-8 (G8) has the accuracy …

Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study

Ocul Immunol Inflamm. 2024 Apr 23:1-8. doi: 10.1080/09273948.2024.2343084. Online ahead of print. ABSTRACT PURPOSES: This study investigated the feasibility of adalimumab (ADA) dose reduction and …